Dolby Laboratories (NYSE: DLB) reported Q3 EPS of $0.86, $0.59 better than the analyst estimate of $0.27. Revenue for the quarter came in at $246.9 million versus the consensus estimate of $232.61 million.

GUIDANCE:

Dolby Laboratories sees Q4 2020 EPS of $0.22-$0.37, versus the consensus of $0.42. Dolby Laboratories sees Q4 2020 revenue of $225-255 million, versus the consensus of $251.74 million.

Dolby Laboratories sees FY2020 EPS of $2.76-$2.91, versus the consensus of $2.36. Dolby Laboratories sees FY2020 revenue of $1.12-1.15 billion, versus the consensus of $1.13 billion.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.